RBC
RARE icon

Roble Belko & Company’s Ultragenyx Pharmaceutical RARE Stock Holding History

Roble Belko & Company’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-44
Closed -$3K – 339
2017
Q1 		$3K Hold
44
– – ﹤0.01% 292
2016
Q4 		$3K Buy
+44
New +$3K ﹤0.01% 311